A pilot study discovered that the FSHR Ser680Asn genotype does not influence the follicular fluid hormonal profile or ovulation outcomes in cycles stimulated with varying gonadotropin preparations. The research, involving 40 women undergoing ART, compared two genetic variants and determined no significant impact on treatment results.
Read More
Chelsea Secures Rising Star Omari Kellyman from Aston Villa in £19 Million Deal
Opposition Grows as Kash Patel Confirmed as New FBI Director
Atalanta Triumphs Over AC Milan to Claim Serie A Leadership
Thomas Partey Charged With Five Counts of Rape by British Police
Cavan Sullivan Sets New Record as Youngest MLS Debutant at 14
